MedPath

University Of California, San Francisco

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Self-monitoring and Reminder Texts to Increase Physical Activity After Cancer: a Pilot Randomized Controlled Trial

Not Applicable
Completed
Conditions
Rectum Cancer
Colon Cancer
Interventions
Behavioral: Digital Health Physical Activity Intervention Group
First Posted Date
2016-11-17
Last Posted Date
2018-04-09
Lead Sponsor
University of California, San Francisco
Target Recruit Count
42
Registration Number
NCT02966054
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of California, San Francisco, San Francisco, California, United States

4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2

Active, not recruiting
Conditions
Cortical-basal Ganglionic Degeneration (CBGD)
Nonfluent Variant Primary Progressive Aphasia (nfvPPA)
Progressive Supranuclear Palsy (PSP)
Oligosymptomatic/Variant Progressive Supranuclear Palsy (o/vPSP)
Corticobasal Degeneration (CBD)
Corticobasal Syndrome (CBS)
Interventions
Other: Observational Study
First Posted Date
2016-11-17
Last Posted Date
2024-01-23
Lead Sponsor
University of California, San Francisco
Target Recruit Count
232
Registration Number
NCT02966145
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of California, San Diego (UCSD), San Diego, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of California, San Francisco (UCSF), San Francisco, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins University, Baltimore, Maryland, United States

and more 5 locations

Interactive Mobile Doctor (iMD) for Asian Smokers

Not Applicable
Completed
Conditions
Smoking Cessation
Interventions
Behavioral: iMD
Behavioral: NPA
First Posted Date
2016-11-17
Last Posted Date
2020-05-05
Lead Sponsor
University of California, San Francisco
Target Recruit Count
172
Registration Number
NCT02966132
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Asian Health Services, Oakland, California, United States

Survivor Choices for Eating and Drinking - Colorectal Cancer

Not Applicable
Completed
Conditions
Rectal Cancer
ColoRectal Cancer
Colon Cancer
Interventions
Behavioral: Website and text messages
First Posted Date
2016-11-16
Last Posted Date
2018-12-21
Lead Sponsor
University of California, San Francisco
Target Recruit Count
50
Registration Number
NCT02965521
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of California, San Francisco, San Francisco, California, United States

The Effects of BCRP Q141K on Allopurinol Pharmacokinetics and Dynamics

Phase 4
Completed
Conditions
Chronic Gout
Hyperuricemia
Interventions
Drug: Allopurinol
Other: Placebo
First Posted Date
2016-11-06
Last Posted Date
2020-06-23
Lead Sponsor
University of California, San Francisco
Target Recruit Count
27
Registration Number
NCT02956278
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Open Medicine Institute, Mountain View, California, United States

Statewide Communication to Reach Diverse Low Income Women

Not Applicable
Completed
Conditions
Hereditary Breast and Ovarian Cancer Syndrome
Interventions
Behavioral: Delayed Intervention Group
Behavioral: Intervention Group
First Posted Date
2016-11-06
Last Posted Date
2021-10-04
Lead Sponsor
University of California, San Francisco
Target Recruit Count
88
Registration Number
NCT02956681

Study to Understand Gaining Access to Blood Glucose Records

Not Applicable
Completed
Conditions
Diabetes Mellitus
Interventions
Device: Livongo Health System
Device: iHealth Glucose Meter
First Posted Date
2016-11-06
Last Posted Date
2022-08-29
Lead Sponsor
University of California, San Francisco
Target Recruit Count
83
Registration Number
NCT02956642
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of California, San Francisco, San Francisco, California, United States

Vaping THC From Electronic Cigarettes

Phase 3
Completed
Conditions
Marijuana Dependence
Interventions
Drug: Nicotine
Drug: Cannabis
Device: PAX Loose Leaf Vaporizer
First Posted Date
2016-11-04
Last Posted Date
2023-06-29
Lead Sponsor
University of California, San Francisco
Target Recruit Count
8
Registration Number
NCT02955329
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Zuckerberg San Francisco General Hospital, San Francisco, California, United States

Breast Capsular Contracture Following Post-Mastectomy Reconstruction in Women Treated With the Leukotriene Inhibitor Zafirlukast: A Phase II Trial

Phase 2
Terminated
Conditions
Breast Cancer
Interventions
Other: Standard of Care (no intervention)
Drug: zafirlukast
First Posted Date
2016-11-01
Last Posted Date
2019-10-01
Lead Sponsor
University of California, San Francisco
Target Recruit Count
4
Registration Number
NCT02950480
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

Emotion Tracking Study for Residents

Not Applicable
Completed
Conditions
Stress, Emotional
Interventions
Behavioral: EmoTrak
First Posted Date
2016-10-28
Last Posted Date
2020-01-18
Lead Sponsor
University of California, San Francisco
Target Recruit Count
100
Registration Number
NCT02947477
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of California, San Francisco, California, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath